Reproductive technology faces legal and ethical challenges

Discussions surrounding assisted reproductive technology are increasingly focusing on legal disputes and the ethical implications of genetic screening. In Illinois, legal frameworks such as 750 ILCS 46/704.5 govern the disposition of cryopreserved fertilized ova when intended parents no longer agree on their medical use. Disputes often center on whether embryos should be used, destroyed, or kept in storage, with decisions typically guided by prior informed consent forms or marital settlement agreements.

Simultaneously, the rise of polygenic embryo testing is introducing new ethical dilemmas. While preimplantation genetic testing for aneuploidy (PGT-A) is a routine medical practice, newer commercial services offer polygenic scoring to screen for susceptibility to conditions like diabetes and depression, or even non-medical traits such as height and intelligence. Experts warn that these statistical predictions can be misleading, as risk reduction figures may overstate actual health benefits and fail to account for the complex nature of hereditary probabilities.